Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-04

FDA Approved: METHOCARBAMOL — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for methocarbamol filed by Sagent Pharmaceuticals for the generic product. The action authorizes an approved change to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOCARBAMOL (Methocarbamol)

Snippet

SUPPL AP for METHOCARBAMOL (METHOCARBAMOL)